ENERTECK CORP

2023 Q4 Form 10-Q Financial Statement

#000147793223008588 Filed on November 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.440K $370.00
YoY Change 289.19% -95.96%
Cash & Equivalents $1.440K $372.00
Short-Term Investments
Other Short-Term Assets $31.12K $31.91K
YoY Change -2.48% -10.79%
Inventory $182.6K $184.5K
Prepaid Expenses $31.12K $31.91K
Receivables $8.393K $23.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $223.6K $239.7K
YoY Change -6.74% 86.07%
LONG-TERM ASSETS
Property, Plant & Equipment $6.225K $6.289K
YoY Change -1.02% 437.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $37.52K
YoY Change 0.0%
Total Long-Term Assets $96.85K $146.9K
YoY Change -34.09% -4.78%
TOTAL ASSETS
Total Short-Term Assets $223.6K $239.7K
Total Long-Term Assets $96.85K $146.9K
Total Assets $320.4K $386.7K
YoY Change -17.13% 36.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $320.2K $264.0K
YoY Change 21.31% 10.89%
Accrued Expenses $344.1K $291.8K
YoY Change 17.9% -95.81%
Deferred Revenue
YoY Change
Short-Term Debt $4.473M $3.993M
YoY Change 12.02% 19.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.98M $11.83M
YoY Change 9.72% 11.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $12.98M $11.83M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $12.98M $11.83M
YoY Change 9.72% 11.6%
SHAREHOLDERS EQUITY
Retained Earnings -$42.19M -$40.98M
YoY Change 2.97%
Common Stock $36.38K $36.38K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.66M -$11.44M
YoY Change
Total Liabilities & Shareholders Equity $320.4K $386.7K
YoY Change -17.13% 36.56%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Inventory Net
InventoryNet
185316 usd
CY2023Q3 etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3125 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-291276 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
182630 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
31123 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15237 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
223586 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
208538 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001128353
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36380690 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36380690 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36380690 shares
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1235070 shares
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-31981
dei Entity Registrant Name
EntityRegistrantName
ENERTECK CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0929885
dei Entity Address Address Line1
EntityAddressAddressLine1
10701 Corporate Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address City Or Town
EntityAddressCityOrTown
Stafford
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77477
dei City Area Code
CityAreaCode
281
dei Local Phone Number
LocalPhoneNumber
240-1787
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36380690 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1440 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1035 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8393 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6950 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
59375 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
50000 usd
CY2023Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
90625 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
314811 usd
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
100000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
269322 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
269274 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6225 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6273 usd
CY2023Q3 us-gaap Assets
Assets
320436 usd
CY2022Q4 us-gaap Assets
Assets
314811 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
320229 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
276876 usd
CY2023Q3 us-gaap Customer Advances Current
CustomerAdvancesCurrent
47900 usd
CY2022Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
50900 usd
CY2023Q3 etck Amount Accounts Payable Related Parties Current
AmountAccountsPayableRelatedPartiesCurrent
4472500 usd
CY2022Q4 etck Amount Accounts Payable Related Parties Current
AmountAccountsPayableRelatedPartiesCurrent
4112500 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5157814 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4963987 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2637499 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2397780 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
344055 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
301103 usd
CY2023Q3 us-gaap Liabilities
Liabilities
12979997 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12103146 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36380690 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
36381 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
36381 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29495837 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29495837 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42191779 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41320553 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-12659561 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11788335 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
320436 usd
CY2023Q3 us-gaap Revenues
Revenues
27311 usd
CY2022Q3 us-gaap Revenues
Revenues
24031 usd
us-gaap Revenues
Revenues
32811 usd
us-gaap Revenues
Revenues
100091 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3010 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4110 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3995 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25388 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
24301 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
19921 usd
us-gaap Gross Profit
GrossProfit
28816 usd
us-gaap Gross Profit
GrossProfit
74703 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
132093 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
133942 usd
us-gaap Salaries And Wages
SalariesAndWages
400099 usd
us-gaap Salaries And Wages
SalariesAndWages
401950 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3141 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3141 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9423 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9423 usd
CY2023Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
81360 usd
CY2022Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
101654 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
301504 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
304916 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
216594 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
238737 usd
us-gaap Operating Expenses
OperatingExpenses
711026 usd
us-gaap Operating Expenses
OperatingExpenses
716289 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-192293 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-218816 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-682210 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-641586 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
4 usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
2 usd
us-gaap Interest Income Other
InterestIncomeOther
11 usd
us-gaap Interest Income Other
InterestIncomeOther
4 usd
CY2023Q3 us-gaap Other Income
OtherIncome
52746 usd
CY2022Q3 us-gaap Other Income
OtherIncome
3948 usd
us-gaap Other Income
OtherIncome
51705 usd
us-gaap Other Income
OtherIncome
6320 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
83626 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
76410 usd
us-gaap Interest Expense
InterestExpense
240732 usd
us-gaap Interest Expense
InterestExpense
221675 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-223169 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-291276 usd
us-gaap Net Income Loss
NetIncomeLoss
-871226 usd
us-gaap Net Income Loss
NetIncomeLoss
-856937 usd
CY2023Q3 etck Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
CY2022Q3 etck Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
etck Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.02
etck Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.02
CY2022Q3 etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-10585987 usd
us-gaap Net Income Loss
NetIncomeLoss
-856937 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-11442924 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11788335 usd
us-gaap Net Income Loss
NetIncomeLoss
-871226 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-12659561 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-11151648 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-291276 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-11442924 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12436392 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-223169 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-12659561 usd
us-gaap Profit Loss
ProfitLoss
-871226 usd
us-gaap Profit Loss
ProfitLoss
-856937 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9423 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9423 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1443 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23001 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2686 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-104765 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-15886 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-17190 usd
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-3000 usd
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
79473 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
90516 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
239719 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
220313 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
193827 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
161475 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
42952 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
38823 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-695 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-323475 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-482038 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5224 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5224 usd
etck Proceeds From Financing Prepaid Insurance
ProceedsFromFinancingPrepaidInsurance
0 usd
etck Proceeds From Financing Prepaid Insurance
ProceedsFromFinancingPrepaidInsurance
0 usd
etck Payments On Prepaid Insurance Financing
PaymentsOnPrepaidInsuranceFinancing
36120 usd
etck Payments On Prepaid Insurance Financing
PaymentsOnPrepaidInsuranceFinancing
35991 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
360000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
500000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
323880 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
464009 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
405 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-23253 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1035 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23625 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1440 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
372 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
1085 usd
etck Financed Portion Of Prepaid Insurance
FinancedPortionOfPrepaidInsurance
51571 usd
etck Financed Portion Of Prepaid Insurance
FinancedPortionOfPrepaidInsurance
46293 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In preparing the accompanying interim unaudited condensed consolidated financial statements, management has made certain estimates and assumptions that affect reported amounts in the interim unaudited condensed consolidated financial statements and disclosures of contingencies. Actual results may differ from those estimates.</p>
us-gaap Production Costs
ProductionCosts
77000 usd
CY2022 us-gaap Production Costs
ProductionCosts
79000 usd
CY2023Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
8393 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
6950 usd
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6722 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6722 usd
CY2023Q3 etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3125 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9375 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9375 usd
CY2022Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
695 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 usd
CY2023Q3 us-gaap Revenues
Revenues
27311 usd
CY2022Q3 us-gaap Revenues
Revenues
24031 usd
us-gaap Revenues
Revenues
32811 usd
us-gaap Revenues
Revenues
100091 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-223169 usd
us-gaap Net Income Loss
NetIncomeLoss
-871226 usd
us-gaap Net Income Loss
NetIncomeLoss
-856937 usd
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
30909 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
30909 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
244638 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
244638 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
275547 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
275547 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
269322 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
269274 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6225 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6273 usd
CY2023Q3 us-gaap Depreciation
Depreciation
16 usd
CY2022Q3 us-gaap Depreciation
Depreciation
16 usd
us-gaap Depreciation
Depreciation
48 usd
us-gaap Depreciation
Depreciation
48 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-223169 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-291276 usd
us-gaap Net Income Loss
NetIncomeLoss
-871226 usd
us-gaap Net Income Loss
NetIncomeLoss
-856937 usd
CY2022Q3 etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
CY2023Q3 etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2022Q3 etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.02
etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.02
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4940000 shares
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
4940000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
530877 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1235070 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
530877 shares
etck Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueExpired
0.11
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
etck Weighted Average Fair Value Grant Date Exercised
WeightedAverageFairValueGrantDateExercised
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
etck Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueForfeited
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.33
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
704193 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y10M6D
CY2023Q3 etck Sharebased Compensation Arrangement By Sharebased Payment Award Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardNonvestedWeightedAverageGrantDateFairValue
0.07
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.33
etck Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Vested And Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingVestedAndExercisable
704193 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y10M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.07
CY2009Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
100000 usd
CY2009Q3 etck Debt Instrument Interest Rates Stated Percentage
DebtInstrumentInterestRatesStatedPercentage
0.12 pure
CY2013Q4 us-gaap Proceeds From Grantors
ProceedsFromGrantors
1000000.0 usd
CY2023Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
CY2022Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
14284 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
14284 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
42984 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
42851 usd

Files In Submission

Name View Source Status
0001477932-23-008588-index-headers.html Edgar Link pending
0001477932-23-008588-index.html Edgar Link pending
0001477932-23-008588.txt Edgar Link pending
0001477932-23-008588-xbrl.zip Edgar Link pending
etck-20230930.xsd Edgar Link pending
etck_10q.htm Edgar Link pending
etck_ex311.htm Edgar Link pending
etck_ex312.htm Edgar Link pending
etck_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
etck-20230930_cal.xml Edgar Link unprocessable
etck-20230930_def.xml Edgar Link unprocessable
etck-20230930_lab.xml Edgar Link unprocessable
etck-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
etck_10q_htm.xml Edgar Link completed